5-131171033-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181705.4(LYRM7):āc.13G>Cā(p.Val5Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000724 in 1,382,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_181705.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LYRM7 | NM_181705.4 | c.13G>C | p.Val5Leu | missense_variant | 1/5 | ENST00000379380.9 | |
LYRM7 | NM_001293735.2 | c.13G>C | p.Val5Leu | missense_variant | 1/4 | ||
LYRM7 | NR_121658.2 | n.90G>C | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LYRM7 | ENST00000379380.9 | c.13G>C | p.Val5Leu | missense_variant | 1/5 | 1 | NM_181705.4 | P1 | |
LYRM7 | ENST00000507584.1 | c.13G>C | p.Val5Leu | missense_variant | 1/4 | 2 | |||
LYRM7 | ENST00000510516.5 | c.13G>C | p.Val5Leu | missense_variant | 1/3 | 2 | |||
HINT1 | ENST00000506207.2 | n.236+573C>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.24e-7 AC: 1AN: 1382078Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 685566
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.13G>C (p.V5L) alteration is located in exon 1 (coding exon 1) of the LYRM7 gene. This alteration results from a G to C substitution at nucleotide position 13, causing the valine (V) at amino acid position 5 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at